Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MedPAC Recommends Outpatient Rx Handling Fee For Hospital Pharmacies

This article was originally published in The Pink Sheet Daily

Executive Summary

The Hospital Outpatient Prospective Payment System should include a payment adjustment for pharmaceutical handling costs, the Medicare Payment Advisory Committee recommended during an April 21 meeting in Washington, D.C

You may also be interested in...



Hospital Outpatient Drugs To Be Reimbursed ASP+8% Under Medicare In 2006

CMS issues hospital Outpatient Prospective Payment System proposed rule for 2006. Reimbursement for specified covered outpatient drugs would be switched from the current 83% of average wholesale price to average sales price plus 8% in 2006; the rate includes ASP+6% for drug acquisition costs, plus 2% of ASP for "overhead" costs.

Hospital Outpatient Drugs To Be Reimbursed ASP+8% Under Medicare In 2006

CMS issues hospital Outpatient Prospective Payment System proposed rule for 2006. Reimbursement for specified covered outpatient drugs would be switched from the current 83% of average wholesale price to average sales price plus 8% in 2006; the rate includes ASP+6% for drug acquisition costs, plus 2% of ASP for "overhead" costs.

Dialysis Drug Reimbursement Should Be Based Solely On ASP, MedPAC Says

Medicare Payment Advisory Committee unanimously recommends average sales price-based reimbursement for dialysis drugs in all settings. More timely updating of payment rates is cited as the main advantage of ASP-based reimbursement over reimbursement based on average acquisition payment.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS062047

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel